DK3468974T3 - Nye piperidinyl-derivativer, en fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger indeholdende dem - Google Patents

Nye piperidinyl-derivativer, en fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger indeholdende dem Download PDF

Info

Publication number
DK3468974T3
DK3468974T3 DK17727927.0T DK17727927T DK3468974T3 DK 3468974 T3 DK3468974 T3 DK 3468974T3 DK 17727927 T DK17727927 T DK 17727927T DK 3468974 T3 DK3468974 T3 DK 3468974T3
Authority
DK
Denmark
Prior art keywords
procedure
preparation
pharmaceutical compositions
compositions containing
piperidinyl derivatives
Prior art date
Application number
DK17727927.0T
Other languages
English (en)
Inventor
Alba Macias
James Brooke Murray
Olivier Geneste
Didier Demarles
Elodie Lewkowicz
Maïa Chanrion
Árpád Kiss
András Kotschy
Balázs Molnár
Attila Vasas
Csaba Wéber
Original Assignee
Servier Lab
Vernalis R&D Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab, Vernalis R&D Ltd filed Critical Servier Lab
Application granted granted Critical
Publication of DK3468974T3 publication Critical patent/DK3468974T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK17727927.0T 2016-06-10 2017-06-09 Nye piperidinyl-derivativer, en fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger indeholdende dem DK3468974T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1655392A FR3052452B1 (fr) 2016-06-10 2016-06-10 Nouveaux derives de piperidinyle, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PCT/EP2017/064067 WO2017212012A1 (en) 2016-06-10 2017-06-09 New piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them

Publications (1)

Publication Number Publication Date
DK3468974T3 true DK3468974T3 (da) 2020-05-11

Family

ID=56943687

Family Applications (1)

Application Number Title Priority Date Filing Date
DK17727927.0T DK3468974T3 (da) 2016-06-10 2017-06-09 Nye piperidinyl-derivativer, en fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger indeholdende dem

Country Status (45)

Country Link
US (1) US11046681B2 (da)
EP (1) EP3468974B1 (da)
JP (1) JP6928005B2 (da)
KR (1) KR20190016106A (da)
CN (1) CN109311888B (da)
AR (1) AR108706A1 (da)
AU (1) AU2017277734B2 (da)
BR (1) BR112018075433A2 (da)
CA (1) CA3027014C (da)
CL (1) CL2018003474A1 (da)
CO (1) CO2018013210A2 (da)
CR (1) CR20180564A (da)
CU (1) CU20180145A7 (da)
CY (1) CY1122870T1 (da)
DK (1) DK3468974T3 (da)
DO (1) DOP2018000270A (da)
EA (1) EA037211B1 (da)
EC (1) ECSP18090144A (da)
ES (1) ES2775789T3 (da)
FR (1) FR3052452B1 (da)
GE (1) GEP20207160B (da)
HR (1) HRP20200361T1 (da)
HU (1) HUE049507T2 (da)
IL (1) IL263463B (da)
LT (1) LT3468974T (da)
MA (1) MA45222B1 (da)
MD (1) MD3468974T2 (da)
ME (1) ME03670B (da)
MX (1) MX2018015216A (da)
MY (1) MY196562A (da)
NI (1) NI201800132A (da)
PE (1) PE20220567A1 (da)
PH (1) PH12018502515B1 (da)
PL (1) PL3468974T3 (da)
PT (1) PT3468974T (da)
RS (1) RS60029B1 (da)
RU (1) RU2743163C2 (da)
SG (1) SG11201810629QA (da)
SI (1) SI3468974T1 (da)
SV (1) SV2018005791A (da)
TN (1) TN2018000410A1 (da)
TW (1) TWI620750B (da)
UA (1) UA123794C2 (da)
UY (1) UY37288A (da)
WO (1) WO2017212012A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10179792B2 (en) 2016-03-07 2019-01-15 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
AU2018254577B2 (en) 2017-04-21 2024-06-13 Epizyme, Inc. Combination therapies with EHMT2 inhibitors
BR112020004112A2 (pt) 2017-08-28 2020-09-24 Enanta Pharmaceuticals, Inc. agentes antiviras da hepatite b
TW201925202A (zh) * 2017-11-29 2019-07-01 法商施維雅藥廠 新穎哌啶基衍生物、其製備方法及含其之醫藥組合物
GB201801562D0 (en) * 2018-01-31 2018-03-14 Almac Diagnostics Ltd Pharmaceutical compounds
UY38291A (es) * 2018-07-05 2020-06-30 Servier Lab Nuevos derivados de amino-pirimidonilo un proceso para su preparación y composiciones farmacéuticas
UY38383A (es) 2018-09-21 2020-04-30 Enanta Pharm Inc Heterociclos funcionalizados como agentes antivirales
UY38423A (es) * 2018-10-19 2021-02-26 Servier Lab Nuevos derivados amino-pirimidonil-piperidinilo, un proceso para su preparación y composiciones farmacéuticas que los contienen
EP3883570A4 (en) 2018-11-21 2022-07-13 Enanta Pharmaceuticals, Inc. FUNCTIONALIZED HETEROCYCLES AS ANTIVIRAL AGENTS
EP3890829A1 (en) * 2018-12-06 2021-10-13 Almac Discovery Limited Pharmaceutical compounds and their use as inhibitors of ubiquitin specific protease 19 (usp19)
US11236111B2 (en) 2019-06-03 2022-02-01 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
US11472808B2 (en) 2019-06-04 2022-10-18 Enanta Pharmaceuticals, Inc. Substituted pyrrolo[1,2-c]pyrimidines as hepatitis B antiviral agents
US11760755B2 (en) 2019-06-04 2023-09-19 Enanta Pharmaceuticals, Inc. Hepatitis B antiviral agents
US11738019B2 (en) 2019-07-11 2023-08-29 Enanta Pharmaceuticals, Inc. Substituted heterocycles as antiviral agents
WO2021055425A2 (en) 2019-09-17 2021-03-25 Enanta Pharmaceuticals, Inc. Functionalized heterocycles as antiviral agents
CN113087718B (zh) * 2020-01-09 2024-02-09 四川科伦博泰生物医药股份有限公司 噻吩并嘧啶酮类化合物及其医药应用
CN112608320B (zh) * 2020-01-16 2023-03-17 中国药科大学 哌啶类化合物及其制备方法和医药用途
GB202001980D0 (en) 2020-02-13 2020-04-01 Almac Discovery Ltd Therapeutic mentods
US11802125B2 (en) 2020-03-16 2023-10-31 Enanta Pharmaceuticals, Inc. Functionalized heterocyclic compounds as antiviral agents

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070142369A1 (en) * 2005-12-21 2007-06-21 Margaret Van Heek Combination of an H3 antagonist/inverse agonist and an appetite suppressant
US20100093692A1 (en) * 2007-03-02 2010-04-15 Schering Corporation Sechering-Plough Corporation Piperidinyl-piperidine and piperazinyl-piperidine for use in the treatment of diabetes or pain
EP2565186A1 (en) * 2011-09-02 2013-03-06 Hybrigenics S.A. Selective and reversible inhibitors of ubiquitin specific protease 7
TWI698436B (zh) * 2014-12-30 2020-07-11 美商佛瑪治療公司 作為泛素特異性蛋白酶7抑制劑之吡咯并及吡唑并嘧啶
US10654849B2 (en) * 2016-06-10 2020-05-19 Les Laboratoires Servier (Hetero)aryl-substituted-piperidinyl derivatives, a process for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
EA037211B1 (ru) 2021-02-19
LT3468974T (lt) 2020-04-10
PE20220567A1 (es) 2022-04-13
UA123794C2 (uk) 2021-06-02
PT3468974T (pt) 2020-03-25
TW201802092A (zh) 2018-01-16
FR3052452A1 (da) 2017-12-15
AU2017277734B2 (en) 2021-07-01
PH12018502515A1 (en) 2019-09-30
MA45222A (fr) 2019-04-17
CN109311888A (zh) 2019-02-05
UY37288A (es) 2018-01-02
MD3468974T2 (ro) 2020-05-31
ECSP18090144A (es) 2019-01-31
PH12018502515B1 (en) 2019-09-30
EP3468974B1 (en) 2020-02-12
CA3027014C (en) 2021-01-05
RU2018147430A (ru) 2020-07-10
CR20180564A (es) 2019-03-04
MY196562A (en) 2023-04-19
RU2018147430A3 (da) 2020-07-10
US20190144448A1 (en) 2019-05-16
CO2018013210A2 (es) 2018-12-28
BR112018075433A2 (pt) 2019-03-19
AR108706A1 (es) 2018-09-19
US11046681B2 (en) 2021-06-29
MX2018015216A (es) 2019-04-25
EA201892838A1 (ru) 2019-06-28
TN2018000410A1 (en) 2020-06-15
RU2743163C2 (ru) 2021-02-15
NI201800132A (es) 2019-04-08
PL3468974T3 (pl) 2020-07-13
CY1122870T1 (el) 2021-05-05
KR20190016106A (ko) 2019-02-15
CN109311888B (zh) 2021-09-14
SV2018005791A (es) 2019-01-16
JP6928005B2 (ja) 2021-09-01
JP2019517556A (ja) 2019-06-24
CU20180145A7 (es) 2019-07-04
CA3027014A1 (en) 2017-12-14
EP3468974A1 (en) 2019-04-17
HUE049507T2 (hu) 2020-09-28
HRP20200361T1 (hr) 2020-06-12
FR3052452B1 (fr) 2018-06-22
WO2017212012A1 (en) 2017-12-14
IL263463A (en) 2019-01-31
SG11201810629QA (en) 2018-12-28
GEP20207160B (en) 2020-10-12
IL263463B (en) 2021-01-31
SI3468974T1 (sl) 2020-07-31
CL2018003474A1 (es) 2019-05-24
AU2017277734A1 (en) 2018-12-20
DOP2018000270A (es) 2019-05-15
ME03670B (en) 2020-10-20
TWI620750B (zh) 2018-04-11
ES2775789T3 (es) 2020-07-28
RS60029B1 (sr) 2020-04-30
MA45222B1 (fr) 2020-04-30

Similar Documents

Publication Publication Date Title
DK3468974T3 (da) Nye piperidinyl-derivativer, en fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger indeholdende dem
DK3468971T3 (da) Nye (hetero)aryl-substituterede piperidinyl-derivativer, en fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger indeholdende dem
DK3405471T3 (da) Nye ammoniumderivater, en fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger som indeholder dem
DK3313851T3 (da) Nye hydroxyesterderivativer, en fremgangsmåde til deres fremstilling og farmaceutiske sammensætninger indeholdende disse
DK3313849T3 (da) Nye hydroxysyrederivater, fremgangsmåde til fremstilling deraf og farmaceutiske sammensætninger, der indeholder dem
HK1243999A1 (zh) 新型3-吲哚取代的衍生物、藥物組合物及使用方法
DK3313817T3 (da) Bicycliske derivater, fremgansmåde til deres fremstilling og farmaceutiske sammensætninger indeholdende disse
DK3214081T3 (da) Isoindolinderivat, mellemprodukt, fremgangsmåde til fremstilling, farmaceutisk sammensætning og anvendelse deraf
DK3287443T3 (da) 6-leddet heterocyklisk derivat og farmaceutisk sammensætning, som omfatter dette
BR112016022219A2 (pt) formulações farmacêuticas de um inibidor de quinase pan-raf, processos para preparação da mesma e métodos de utilização
DK3464260T3 (da) Forbindelser, der indeholder ureamotiver, og derivater deraf som antibakterielle lægemidler
DK3383397T3 (da) Farmaceutiske sammensætninger indeholdende doravirin, tenofovirdisoproxilfumarat og lamivudin
DK3389633T3 (da) Farmaceutiske sammensætninger, der omfatter phenylaminopyrimidinderivat
DK3555048T3 (da) Nye picolinsyrederivater og deres anvendelse som mellemprodukter
DK3455216T3 (da) Pyridinylderivater, farmaceutiske sammensætninger og anvendelser deraf som aoc3-inhibitorer
DK3290023T3 (da) Farmaceutisk sammensætning med langvarig frigivelse, som indeholder rivastigmin
DK3473631T3 (da) Nye epoxy-funktionelle alkoxysilaner, fremgangsmåde til deres fremstilling og deres anvendelse
DK3233825T3 (da) Diarylmethylidenpiperidinderivater og deres anvendelse som deltaopioidreceptoragonister
DK2974721T3 (da) En farmaceutisk sammensætning omfattende et gasgenererende ingrediens
TH1501002703A (th) สูตรส่วนผสมสำหรับแคปซูลที่มีส้านช้าง ส้านใหญ่ มะตาด เป็นส่วนประกอบ
TH1401007659A (th) อนุพันธ์ไธอีโนไพริมิดีนแบบใหม่กระบวนการในการเตรียมอนุพันธ์ดังกล่าวและองค์ประกอบทางเภสัชกรรมที่ประกอบด้วยอนุพันธ์ดังกล่าว